Category: Blood Diseases
Global Blood Diseases
-
2025 Blood & AutoImmune Diseases Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the blood and blood-forming ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Anemia Drugs
... CAGR of 4.1% over the analysis period 2024-2030. Iron Deficiency Anemia, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the end of the ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Hemophilia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$21.3 Billion by the end of the ... Read More
-
Desmopressin
... 5.6% over the analysis period 2024-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$866.1 Million by the end of the analysis period. Growth ... Read More
-
Plasma Fractionation
... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More
-
2025 Global Forecast for Hemophilia Treatment Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
Acquired Hemophilia Treatment Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Hematology Diagnostics Market Size, Share, and Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy, Leukemia/Lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count (CBC), and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
... Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034 PRODUCT OVERVIEW Hematology Diagnostics Market, valued at USD 4.5 billion in 2023, is anticipated to grow at ... Read More
-
Thalassemia Drugs Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Chemotherapy-Induced Anemia Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Rare Hematology Market - 2024 - 2031
... white blood cells, which makes it challenging to transfer oxygen and fight infections. A few conditions, such hemophagocytic lymphohistiocytosis, can be fatal. Cancerous and non-cancerous blood diseases both exist. The most prevalent non-cancerous blood condition ... Read More
-
Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and ... Read More
-
Global Hemophilia Gene Therapy Industry Growth and Trends Forecast to 2031
... two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and ... Read More
-
Global Sickle Cell Disease Treatment Market - 2025 - 2033
... of 11.3% during the forecast period 2024-2032. Sickle cell disease (SCD) is a group of inherited blood disorders characterized by abnormalities in hemoglobin production. These abnormal hemoglobin cells are sickle-shaped unlike the regular disc-shaped hence ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033 The global biosimilar market size reached USD 26.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 185.1 Billion by 2033, exhibiting ... Read More
-
2025 Global Forecast for Anemia Drugs Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Aplastic Anemia - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Aplastic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Blood Coagulation Testing Market Research Report Information by Product (Consumables and Instruments), by Application (Acquired Bleeding Disorders and Inherited Bleeding Disorders), by Test Type (Prothrombin Time Testing, Activated Partial Thromboplastin Time (aPTT) Testing, Fibrinogen Testing, Activated Clotting Time Testing, Platelet Function Tests, and Others), by End User (Hospitals and Clinics, Diagnostic Centers, Ambulatory Care Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Industry Forecast to 2032
... Activated Clotting Time Testing, Platelet Function Tests, and Others), by End User (Hospitals and Clinics, Diagnostic Centers, Ambulatory Care Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Industry ... Read More
-
Cell and Gene Therapy CRO Market by Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), Type of Genetic Modification (Ex vivo and In vivo), Stage of Development (Discovery, Preclinical, and Clinical), Therapeutic Area (Blood Disorders, Cardiovascular Disorders, Dermatological Disorders, Immunological Disorders, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Neurological Disorders, Oncological Disorders, Rare Diseases, and Other disorders), End-Users (Industry Players and Non-Industry Players) and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... Disorders, Cardiovascular Disorders, Dermatological Disorders, Immunological Disorders, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Neurological Disorders, Oncological Disorders, Rare Diseases, and Other disorders), End-Users (Industry Players and Non-Industry Players) and Key Geographical Regions (North America, Europe, ... Read More
-
Prenatal and Newborn Genetic Testing Market Size, Share, By Product (Diagnostic, and Screening), By Disease (Down's syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia, and Other Diseases), By Technology (Chromosomal Microarray, Polymerase Chain Reaction, Next-Generation Sequencing and Others), By End User (Hospitals, Maternity And Specialty Clinics, and Diagnostic Centers), and By Region - Trends, Analysis and Forecast till 2034
... and Others), By End User (Hospitals, Maternity And Specialty Clinics, and Diagnostic Centers), and By Region - Trends, Analysis and Forecast till 2034 The prenatal and neonatal genetic testing market is experiencing significant growth owing ... Read More
-
2024 Global Plasma Fractionation Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
Research Assistance
